Corticosteroid Therapy in Pregnant Women with Severe COVID-19
Abstract
COVID-19 became a pandemic in a short period of time and so treatment modalities were left behind. Although recently corticosteroids are introduced as life-saving medications in severe COVID-19, there are still debates over their safety and therapeutic approach in pregnancy complicated with severe COVID-19. Here we try to clarify the appropriate use of corticosteroids in this category of patients, especially in those at risk of premature delivery.Key words: COVID-19, corticosteroids, pregnancy, premature delivery
Copyright (c) 2021 Arash Eatemedi, Mohini Abreo, Sirous Golchinheydari, Amal Al Shaaili, Maryam Hashemi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Terms and conditions of Creative Commons Attribution 4.0 International License apply to all published manuscripts. This Journal is licensed under a Creative Commons Attribution 4.0 International License. This licence allows authors to use all articles, data sets, graphics and appendices in data mining applications, search engines, web sites, blogs and other platforms by providing appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
A competing interest exists when professional judgment concerning the validity of research is influenced by a secondary interest, such as financial gain. We require that our authors reveal all possible conflicts of interest in their submitted manuscripts.
The Editor reserves the right to shorten and adjust texts. Significant changes in the text will be agreed with the Authors.
